All Articles by Author:

lbeveridge

Quantitative Proteomics Reveals the Mechanism of Endoplasmic Reticulum Stress-Mediated Pulmonary Fibrosis in Mice

[Heliyon] Investigators utilized quantitative proteomics to investigate the mechanism of TGF-β-induced fibrosis-like changes in mouse epithelial cells. Their findings revealed that TGF-β significantly impacted biological processes related to the endoplasmic reticulum, mitochondrion, and ribonucleoprotein complex.

Choice of Wedge Resection for Selected T1a/bN0M0 Non-Small Cell Lung Cancer

[Scientific Reports] Patients with early-stage NSCLC with a tumor size ≤ 2.0 cm were chosen from the SEER database. The influence of confounding factors was minimized by 1:1 propensity score matching.

Loss of miR-200c-3p Promotes Resistance to Radiation Therapy via the DNA Repair Pathway in Prostate Cancer

[Cell Death & Disease] Investigators found that IRE1α signaling, one of the canonical UPR arms, is increased in prostate cancer patient tumors.

Non-Enzymatic Electrochemical Detection of Sarcosine in Serum of Prostate Cancer Patients by CoNiWBO/rGO Nanocomposite

[Scientific Reports] A reduced graphene oxide-cobalt nickel tungsten boron oxide nanocomposite was synthesized by the chemical reduction method via a one-pot reduction method followed by calcination at 500°C under a nitrogen environment for two hours and characterized by UV-Vis, XRD, TGA, and SEM.

Correlation of PSA and Survival in Metastatic Hormone-Sensitive Prostate Cancer Treated with Rezvilutamide plus ADT in the CHART Trial

[Med] Researchers conducted an exploratory analysis of the CHART trial which investigated prostate-specific antigen (PSA) kinetics and the correlation between PSA and survival outcomes in high-volume, metastatic, hormone-sensitive prostate cancer.

Unveiling LGR5: Prostate Cancer’s Hidden Stem Cell and Treatment Target

[Urologic Oncology-Seminars and Original Investigations] The authors examine the molecular mechanisms associated with LGR5 and emphasizes methodologies aimed at targeting LGR5 to enhance understanding and promote the development of LGR5-specific therapies.

Popular

Microbiotica Announces First Patient Dosed in Its International Phase Ib Trial, MELODY-1 of MB097 Precision Microbiome Co-Therapy in Advanced Melanoma

[Microbiotica] Microbiotica announced that the first patient has been dosed in its advanced melanoma (MELODY-1) trial. This international trial is due to recruit up to 40 patients at clinical centres in the UK, France, Italy, and Spain.

Spatial Proteomics Identifies JAKi as Treatment for a Lethal Skin Disease

[Nature] Scientists analyzed formalin-fixed, paraffin-embedded, archived skin tissue biopsies of three types of cutaneous drug reactions with varying severity and quantified more than 5,000 proteins in keratinocytes and skin-infiltrating immune cells.

Secreted Apoe Rewires Melanoma Cell State Vulnerability to Ferroptosis

[Science Advances] Researchers identified Apolipoprotein E as the top lipid-metabolism gene segregating the melanoma MITFhigh/AXLlow proliferative/ferroptosis-resistant from MITFlow/AXLhigh invasive/ferroptosis-sensitive state.